Physician profile
James Ross
NPI 1508228750
$2,593.97
in general payments reported to CMS, 2019-2025
8 companies · $750 in 2025
The $750 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.42 · 2022: $90.96 · 2023: $849 · 2024: $807 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Travel and Lodging: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.29 |
| Travel and Lodging | $460.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $829.07 | 2023-2025 | Interstim |
| Boston Scientific Corporation | $783.73 | 2021-2025 | Advantage System, Upsylon, Solyx Sis System |
| Coloplast Corp | $463.53 | 2023-2024 | Saffron |
| Abbott Laboratories | $181.39 | 2023-2025 | Triclip, Mitraclip |
| Caldera Medical, INC | $152.45 | 2023-2025 | Desara |
| Axonics, INC. | $140.17 | 2023-2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $27.95 | 2024 | Gemtesa |
| Coopersurgical, INC. | $15.68 | 2023 | Advincula Delineator Uterine Manipulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.